Sumita Bhatta

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

Jason Chesney, Antoni Ribas, Georgina V. Long et al. · Journal of Clinical Oncology · 2022 · 284 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

National Trends In Spending On And Use Of Oral Oncologics, First Quarter 2006 Through Third Quarter 2011

Rena M. Conti, Adam J. Fein, Sumita Bhatta · Health Affairs · 2014 · 54 citations

Pharmacy, Oncology, Pharmaceutical Policy +13

Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data

Christopher Kim, Sumita Bhatta, Lori Cyprien et al. · Journal of bone oncology · 2018 · 41 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

J. Randolph Hecht, Steven S. Raman, Arlene Chan et al. · ESMO Open · 2023 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer

Sumita Bhatta, Ningqi Hou, Zakiya Moton et al. · SpringerPlus · 2013 · 27 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12